top of page

The Mission

The Antimicrobial Stewardship Program aims to optimize antimicrobial effectiveness using a structured institutional approach while minimizing the potential for adverse events, antimicrobial drug resistance and costs. 

Objectives 

  • Advising best practice policies and guidelines for the use of antimicrobial agents at the MUHC;

  • Educating health professionals on matters related to antimicrobials and their appropriate use;

  • Tracking (surveillance) antimicrobial use within the institution;

  • Reporting (feedback) information on antibiotic use and resistance profiles to relevant clinical and administrative staff;

  • Researching the impact of specific interventions on antimicrobial use in the MUHC.

Terms of Reference

ASP Committee Members 

Makeda Semret*

MD MSc FRCP(C) Chair 

Infectious Diseases and Medical Microbiology

Audrey Marcotte

MDCM FRCP(C) MSc Health Care Quality

Emergency Physician and Trauma Emergency Medicine

Daniel Thirion* 

BPharm, MSc, PharmD, FCSHP

Pharmacy 

Vivian Loo 

MD MSc FRCP(C) 

Infectious Diseases and Medical Microbiology

Anne Marie Bourgault* 

MD FRCP(C)

Infectious Diseases and Medical Microbiology

Ruth Horn*

MD FRCP(C)

Infectious Diseases and Medical Microbiology

Donald C. Vinh

MD FRCP(C)

Infectious Diseases and Medical Microbiology

Todd C. Lee

MD MPH FRCP(C)

Internal Medicine and Infectious Diseases 

Marc Dobrescu*

PharmD, MSc

Pharmacy

Tarek Razek

MD CM FRCSC FACS

Trauma and General Surgery

Director of the Adult Trauma Program

Charles Frenette* 

MD FRCP(C)

Infection Prevention and Control (Chair)

Samuel De l'Étoile-Morel

MD FRCP(C)

Chief Resident Infectious Diseases and Medical Microbiology

Keely Hammond

MD FRCP(C) 

Infectious Diseases and Medical Microbiology​

DV profile pic_MUHC-F_Photo shoot_Apr 2023________ (1).png
Screen Shot 2023-07-18 at 9.59.01 AM.png
KeelyHammond-photo.jpg

François Bourdeau* 

PharmD, MSc 

Pharmacy 

Co-Chair and Coordinator

Kelly Davison

PhD, MDCM, FRCP(C)

Hematology-Oncology 

Salman Qureshi

MD FRCP(C)

Respiratory Medicine and Critical Medicine

Nandini Dendukuri

PhD

Centre for Outcome Research and Evaluation

Raphaëlle Lauly*

BPharm, MSc

Pharmacy

Van Dong Nguyen*

PharmD, MSc

Pharmacy

Derek Lee*

BPharm, PharmD

Pharmacy

Alexandre Rivard*

PharmD, MSc

Pharmacy

Kym Archambault*

PharmD, MSc

Pharmacy

Sylvie Carle

BPharm, MSc, FOPQ

Pharmacy

Céline Dupont

BPharm, MSc

Pharmacy

Sébastien Landry*

PharmD, PhD

Pharmacy

Sarah Dabouz

PharmD, MSc

Pharmacy

Messenger_creation_0c7e5037-04b1-4d44-9d03-8e7b57342dd8_edited.jpg
Dr. Queshi.jpg
Kelly Davison - head shot.jpeg
Sebastien Landry
The ASP team is accountable to the ASP committee, which in turn is directly accountable to the MUHC Director of Infectious Diseases (ID) and the Chief of Pharmacy.

*Also part of the ASP audit team. 
Makeda Semret: makeda.semret@mcgill.ca
François Bourdeau: francois.bourdeau@muhc.mcgill.ca
logo2.png

1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada

+1 514-934-1934

bottom of page